U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 17-23, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 17-23, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 03/18/2024
Location: College Park, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: DONALD PRATER; REBECCA BUCKNER; PETER KOUFOPOULOS; JULIE MOSS;
Non FDA Participant/Group: Bede Corry (New Zealand; Ambassador to the United States); Ed McIsaac (New Zealand; Trade Counsellor, Ministry of Foreign Affairs and Trade);

Event Date: 03/19/2024
Location: College Park, MD
Subject: Food Waste
FDA Participant/Group: KARI BARRETT; LAUREN FINNEGAN; PRIYAMVADA KADAM; GLENDA LEWIS; PETER KOUFOPOULOS;
Non FDA Participant/Group: Several members of the Zero Food Waste Coalition

Event Date: 03/19/2024
Location: College Park, MD
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: LATASHA ROBINSON; REBECCA BUCKNER; DONALD PRATER; JESSICA ROWDEN;
Non FDA Participant/Group: Anne MacMillan, Miguel Del Toro, Nancy Dowling, Pat Maloney, Shane Grant, Stephanie Goodwin (Danone);

Event Date: 03/19/2024
Location: Virtual
Subject: Nutrition and Public Health Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Nutrition Consumer and Public Health Alliance

Event Date: 03/21/2024
Location: San Fransisco, CA
Subject: Future Food-Tech Summit
FDA Participant/Group: KRISTI MULDOON JACOBS; STEPHANIE HICE;
Non FDA Participant/Group: Industry, government, academia, retailers, ingredient providers, and investors

Event Date: 03/21/2024
Location: Berkley, CA
Subject: Introductory Meeting
FDA Participant/Group: KRISTI MULDOON JACOBS;
Non FDA Participant/Group: Martin Mulvihill (SaferMade); Megan Arnet (University of California, Berkeley Center for Green Chemistry); Arlene Blum (Green Science Policy Institute);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 03/21/2024
Location: Washington, DC
Subject: Johns Hopkins University (JHU) Seminar; Speaker: FDA's Role in Developing and Implementing Health Policy and Interactions with Congress
FDA Participant/Group: N/A
Non FDA Participant/Group: Graduate Students of the Master of Arts (MA) Government Program

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 03/19/2024
Location: Washington, DC
Subject: Duke Margolis Enhancing Adoption of Innovative Clinical Trial Approaches; Fireside Chat and Panelist
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and nonprofit groups

Event Date: 03/21/2024
Location: Silver Spring, MD
Subject: Innovations in Clinical Trials
FDA Participant/Group: N/A
Non FDA Participant/Group: Martin Landray (University of Oxford);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/17/2024
Location: Galveston, TX
Subject: Gordon Research Conference; Regulatory Tools Facilitating the Development of Rare Disease Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and research stakeholders

Event Date: 03/19/2024
Location: Virtual
Subject: Charles River 2024 Cell and Gene Therapy Summit; FDA’s Focus for 2024 and Beyond: Cell and Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/19/2024
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: KENNETH CAVANAUGH;
Non FDA Participant/Group: Claudette Bedeau, Graeme Tunbridge, Manuela Gazzard (BSI Group (British Standards Institution));

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 03/20/2024
Location: Edinburgh, UK
Subject: Introductory Meeting
FDA Participant/Group: KARIN RUDOLPH;
Non FDA Participant/Group: Ben Toll (Society for Research on Nicotine & Tobacco (SRNT));

Event Date: 03/20/2024
Location: Edinburgh, UK
Subject: Society for Research on Nicotine and Tobacco (SNRT) Annual Meeting; Presenter: Update from FDA’s Center for Tobacco Products: Where We've Been and Where We're Going
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Society for Research on Nicotine and Tobacco (SRNT) representatives and conference attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top